![Manfred Zoltobrocki](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Manfred Zoltobrocki
Corporate Officer/Principal bei Lux Biosciences, Inc.
Aktive Positionen von Manfred Zoltobrocki
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Lux Biosciences, Inc.
![]() Lux Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Lux Biosciences, Inc. provides therapies for treatment of ophthalmic diseases. It develops and commercializes medications for ophthalmic diseases. The company was founded by Ulrich M. Grau, Eddy Anglade, Clarke A. Atwell and Sidney L. Weiss in 2006 and is headquartered in Jersey City, NJ. | Corporate Officer/Principal | 21.10.2009 | - |
Karriereverlauf von Manfred Zoltobrocki
Ehemalige bekannte Positionen von Manfred Zoltobrocki
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
NascaCell Technologies AG
![]() NascaCell Technologies AG Pharmaceuticals: MajorHealth Technology Nascacell Technologies Ag. offers improved, broadened and accelerated modern drug discovery. The company provides services like new generation of biomolecules with its Aptamer and Microbody technologies. Support is given to the customers in the areas of drug discovery and target validation. The company was founded in 2003 and is headquartered in Munich, Germany. | Direktor/Vorstandsmitglied | 10.06.2010 | 08.02.2011 |
Epidauros Biotechnologie AG
![]() Epidauros Biotechnologie AG Miscellaneous Commercial ServicesCommercial Services Part of AbbVie, Inc., Epidauros Biotechnologie AG is a German company that specializes in pharmacogenomics research. The company is based in Bernried, Germany. Epidauros Biotechnologie was acquired by Clinical Data BV from Deutsche Effecten & Wechsel Beteiligungs AG on August 23, 2007 for $11.83 million. | Präsident | - | 01.03.2006 |
Aventis Pharma AG | Corporate Officer/Principal | 01.01.2002 | 01.01.2002 |
Hoechst Marion Roussel SA | Corporate Officer/Principal | - | - |
Hoechst Pharmaceuticals Ltd. | Corporate Officer/Principal | - | - |
Ausbildung von Manfred Zoltobrocki
Johann Wolfgang Goethe-Universität Frankfurt am Main | Doctorate Degree |
Statistik
International
Deutschland | 5 |
Vereinigte Staaten | 2 |
Vereinigtes Königreich | 2 |
Operativ
Corporate Officer/Principal | 4 |
President | 1 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 4 |
Commercial Services | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 6 |
---|---|
Lux Biosciences, Inc.
![]() Lux Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Lux Biosciences, Inc. provides therapies for treatment of ophthalmic diseases. It develops and commercializes medications for ophthalmic diseases. The company was founded by Ulrich M. Grau, Eddy Anglade, Clarke A. Atwell and Sidney L. Weiss in 2006 and is headquartered in Jersey City, NJ. | Health Technology |
Epidauros Biotechnologie AG
![]() Epidauros Biotechnologie AG Miscellaneous Commercial ServicesCommercial Services Part of AbbVie, Inc., Epidauros Biotechnologie AG is a German company that specializes in pharmacogenomics research. The company is based in Bernried, Germany. Epidauros Biotechnologie was acquired by Clinical Data BV from Deutsche Effecten & Wechsel Beteiligungs AG on August 23, 2007 for $11.83 million. | Commercial Services |
Aventis Pharma AG | |
Hoechst Pharmaceuticals Ltd. | |
Hoechst Marion Roussel SA | Health Technology |
NascaCell Technologies AG
![]() NascaCell Technologies AG Pharmaceuticals: MajorHealth Technology Nascacell Technologies Ag. offers improved, broadened and accelerated modern drug discovery. The company provides services like new generation of biomolecules with its Aptamer and Microbody technologies. Support is given to the customers in the areas of drug discovery and target validation. The company was founded in 2003 and is headquartered in Munich, Germany. | Health Technology |
- Börse
- Insiders
- Manfred Zoltobrocki
- Erfahrung